✦ LIBER ✦

Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital

✍ Scribed by G. Heinemeyer; H. J. Gramm; W. Simgen; R. Dennhardt; I. Roots

Publisher: Springer
Year: 1987
Tongue: English
Weight: 630 KB
Volume: 32
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00607575

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Septicaemia in critical care patients tr

Septicaemia in critical care patients treated with high doses of antibiotics

✍ F. Lackner; W. Haider; S. Orbes; H. Pichler; M. Rotter; H.P. Werner 📂 Article 📅 1974 🏛 Elsevier Science 🌐 English ⚖ 353 KB

Pharmacokinetics of thiopental after sin

Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients

✍ H. Russo; J. Brès; M. P. Duboin; B. Roquefeuil 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 967 KB

Thiopental was administered to neurosurgical patients for cerebral protection and its pharmacokinetic parameters were determined after a single bolus of 540, 1000 or 1500 mg (3 subjects) or after multiple doses of 250 mg (5 subjects) and 500 mg (2 subjects) every two hours for up to 7 days. The data

Protein-methotrexate-IgG complexes in th

Protein-methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy

✍ Maria Da Costa; William Isacoff; Sheldon P. Rothenberg; M. Perwaiz Iqbal 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

The kinetics of metamizol and its metabo

The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction

✍ G. Heinemeyer; H. -J. Gramm; I. Roots; R. Dennhardt; W. Simgen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 555 KB

We have studied the clearance of monomethylaminoantipyrine (MMAAP), the pharmacologically active form of metamizol, in 46 patients in surgical intensive care with different degrees of renal dysfunction. In 23 patients without any renal impairment, mean clearance was 2.8 ml.min-1 x kg-1. Twenty-one p

Continuous infusion of high-dose metoclo

Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

✍ R. A. Joss; R. L. Galeazzi; K. W. Brunner 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 580 KB

Vascular events in patients receiving hi

Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: The University of Chicago experience

✍ Gradishar, W. ;Vokes, E. ;Schilsky, R. ;Weichselbaum, R. ;Panje, W. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 822 KB

In a retrospective review, 22 of a total of 244 patients (9%) patients with head and neck or gastrointestinal cancer who were treated with infusional 5-fluorouracil (5-FU)-based chemotherapy regimens experienced thrombotic vascular events. These events occurred concurrently with treatment or several